LOGIN  |  REGISTER
Assertio
Amneal Pharmaceuticals

Sharecare announces inducement grants under Nasdaq Listing Rule 5635(c)(4)

June 19, 2024 | Last Trade: US$1.43 0.00 0.00

ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that helps people manage all their health in one place, today announced that on June 14, 2024, its Board of Directors (the “Board”) adopted the Sharecare, Inc. 2024 Inducement Plan (the “Inducement Plan”), under which the Company may grant inducement equity awards outside of the Sharecare, Inc. 2021 Omnibus Incentive Plan, as amended. The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of the Company (or following a bona fide period of non-employment) as an inducement material to such individuals entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The Company allocated up to 5,000,000 shares of common stock of the Company to be subject to inducement equity awards under the Inducement Plan.

In addition, the Company announced that effective June 14, 2024, the Board has granted inducement equity awards under the Inducement Plan to five new employees. The five employees received a total of 3,389,285 restricted stock units, 1,889,285 of which are time-based restricted stock units (“RSUs”) and 1,500,000 of which are performance-based restricted stock units (“PSUs”). The RSUs vest over three or four years, subject to each employee’s continuous employment on each vesting date. The PSUs granted to one of the new employees provide for cliff vesting at the end of the three-year performance period, with the number of shares to be issued based on annual achievement of defined performance-based vesting conditions and will be subject to the employee’s continuous employment through the vesting date. Other terms of the RSU and PSU grants and any additional grants under the Inducement Plan are as determined by the Board or Compensation Committee and are as set forth in the Inducement Plan and applicable award agreements covering each grant.

For more information, visit investors.sharecare.com.

About Sharecare

Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

Contacts: 
Media: This email address is being protected from spambots. You need JavaScript enabled to view it.Investors: This email address is being protected from spambots. You need JavaScript enabled to view it.

Recursion

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB